Cargando…
Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial”
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339609/ https://www.ncbi.nlm.nih.gov/pubmed/34364698 http://dx.doi.org/10.1016/j.clinthera.2021.07.006 |
| _version_ | 1783733638261637120 |
|---|---|
| author | Shahbaznejad, Leila Davoudi, Alireza Eslami, Gohar Markowitz, John S. Navaeifar, Mohammad Reza Hosseinzadeh, Fatemeh Movahedi, Faeze Sadat Rezai, Mohammad Sadegh |
| author_facet | Shahbaznejad, Leila Davoudi, Alireza Eslami, Gohar Markowitz, John S. Navaeifar, Mohammad Reza Hosseinzadeh, Fatemeh Movahedi, Faeze Sadat Rezai, Mohammad Sadegh |
| author_sort | Shahbaznejad, Leila |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8339609 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83396092021-08-06 Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” Shahbaznejad, Leila Davoudi, Alireza Eslami, Gohar Markowitz, John S. Navaeifar, Mohammad Reza Hosseinzadeh, Fatemeh Movahedi, Faeze Sadat Rezai, Mohammad Sadegh Clin Ther Correspondence Elsevier Inc. 2021-09 2021-08-05 /pmc/articles/PMC8339609/ /pubmed/34364698 http://dx.doi.org/10.1016/j.clinthera.2021.07.006 Text en © 2021 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Shahbaznejad, Leila Davoudi, Alireza Eslami, Gohar Markowitz, John S. Navaeifar, Mohammad Reza Hosseinzadeh, Fatemeh Movahedi, Faeze Sadat Rezai, Mohammad Sadegh Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
| title | Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
| title_full | Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
| title_fullStr | Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
| title_full_unstemmed | Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
| title_short | Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial” |
| title_sort | response to letter regarding article, “effects of ivermectin in patients with covid-19: a multicenter, double-blind, randomized, controlled clinical trial” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339609/ https://www.ncbi.nlm.nih.gov/pubmed/34364698 http://dx.doi.org/10.1016/j.clinthera.2021.07.006 |
| work_keys_str_mv | AT shahbaznejadleila responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT davoudialireza responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT eslamigohar responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT markowitzjohns responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT navaeifarmohammadreza responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT hosseinzadehfatemeh responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT movahedifaezesadat responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial AT rezaimohammadsadegh responsetoletterregardingarticleeffectsofivermectininpatientswithcovid19amulticenterdoubleblindrandomizedcontrolledclinicaltrial |